186 related articles for article (PubMed ID: 38663316)
21. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
[TBL] [Abstract][Full Text] [Related]
22. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.
Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y
Free Radic Biol Med; 2024 Jun; 222():130-148. PubMed ID: 38866192
[TBL] [Abstract][Full Text] [Related]
23. Cuproptosis: Unraveling the Mechanisms of Copper-Induced Cell Death and Its Implication in Cancer Therapy.
Springer C; Humayun D; Skouta R
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339398
[TBL] [Abstract][Full Text] [Related]
24. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
[TBL] [Abstract][Full Text] [Related]
25. Cuproptosis: p53-regulated metabolic cell death?
Xiong C; Ling H; Hao Q; Zhou X
Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of cuproptosis in Parkinson's disease.
Huang M; Zhang Y; Liu X
Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
[TBL] [Abstract][Full Text] [Related]
27. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
[TBL] [Abstract][Full Text] [Related]
28. Copper homeostasis dysregulation in respiratory diseases: a review of current knowledge.
Song W; Yue Y; Zhang Q; Wang X
Front Physiol; 2024; 15():1243629. PubMed ID: 38883186
[TBL] [Abstract][Full Text] [Related]
29. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.
Zhao J; Guo S; Schrodi SJ; He D
Front Immunol; 2022; 13():930278. PubMed ID: 35990673
[TBL] [Abstract][Full Text] [Related]
30. Copper homeostasis and cuproptosis in cancer immunity and therapy.
Liu WQ; Lin WR; Yan L; Xu WH; Yang J
Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
[TBL] [Abstract][Full Text] [Related]
31. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
Yang L; Yang P; Lip GYH; Ren J
Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
[TBL] [Abstract][Full Text] [Related]
32. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
[TBL] [Abstract][Full Text] [Related]
33. Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug.
Gao J; Wu X; Huang S; Zhao Z; He W; Song M
Redox Biol; 2023 Nov; 67():102891. PubMed ID: 37734229
[TBL] [Abstract][Full Text] [Related]
34. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
[TBL] [Abstract][Full Text] [Related]
35. Cuproptosis-a potential target for the treatment of osteoporosis.
Li D; Gao Z; Li Q; Liu X; Liu H
Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
[TBL] [Abstract][Full Text] [Related]
36. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
Han J; Luo J; Wang C; Kapilevich L; Zhang XA
Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
[TBL] [Abstract][Full Text] [Related]
37. Targeting cuproplasia and cuproptosis in cancer.
Tang D; Kroemer G; Kang R
Nat Rev Clin Oncol; 2024 May; 21(5):370-388. PubMed ID: 38486054
[TBL] [Abstract][Full Text] [Related]
38. Cuproptosis identifies respiratory subtype of renal cancer that confers favorable prognosis.
Li K; Tan L; Li Y; Lyu Y; Zheng X; Jiang H; Zhang X; Wen H; Feng C
Apoptosis; 2022 Dec; 27(11-12):1004-1014. PubMed ID: 36103026
[TBL] [Abstract][Full Text] [Related]
39. Tumor Microenvironment Responsive Hollow Nanoplatform for Triple Amplification of Oxidative Stress to Enhance Cuproptosis-Based Synergistic Cancer Therapy.
Xu W; Wang Y; Hou G; Wang J; Wang T; Qian J; Suo A
Adv Healthc Mater; 2023 May; 12(13):e2202949. PubMed ID: 36716523
[TBL] [Abstract][Full Text] [Related]
40. Copper-dependent autophagic degradation of GPX4 drives ferroptosis.
Xue Q; Yan D; Chen X; Li X; Kang R; Klionsky DJ; Kroemer G; Chen X; Tang D; Liu J
Autophagy; 2023 Jul; 19(7):1982-1996. PubMed ID: 36622894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]